XML 62 R52.htm IDEA: XBRL DOCUMENT v3.25.3
SUBSEQUENT EVENTS (Details) - Subsequent Event - USD ($)
$ / shares in Units, $ in Millions
1 Months Ended
Oct. 20, 2025
Oct. 15, 2025
Oct. 31, 2025
Takeda Pharmaceuticals U.S.A., Inc.      
Subsequent Event [Line Items]      
Licenses agreement, planned stockholder distribution from proceeds, percentage     25.00%
ADAR1 Repurchase Agreement      
Subsequent Event [Line Items]      
Shares acquired, average cost per share (in USD per share)   $ 17.75  
Treasury stock, shares, acquired (in shares)   10,176,595  
Aggregate purchase price   $ 180.6  
Treasury stock, shares consideration received on commencement of tender offer (in shares) $ 194.4    
Shares acquired, price per share on commencement of tender offer (in USD per share) $ 17.75